Citizens Financial Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.89M Buy
80,552
+28,098
+54% +$1.64M 0.07% 185
2025
Q4
$2.83M Buy
52,454
+3,171
+6% +$153K 0.04% 235
2025
Q3
$2.22M Buy
49,283
+5,070
+11% +$237K 0.03% 269
2025
Q2
$2.05M Buy
44,213
+8,876
+25% +$436K 0.03% 255
2025
Q1
$2.16M Buy
35,337
+5,395
+18% +$314K 0.04% 227
2024
Q4
$1.69M Sell
29,942
-3,053
-9% -$171K 0.03% 238
2024
Q3
$1.71M Sell
32,995
-2,208
-6% -$104K 0.03% 233
2024
Q2
$1.46M Buy
35,203
+8,070
+30% +$361K 0.03% 237
2024
Q1
$1.47M Sell
27,133
-560
-2% -$28.5K 0.05% 177
2023
Q4
$1.42M Buy
27,693
+1,646
+6% +$86.4K 0.05% 187
2023
Q3
$1.51M Sell
26,047
-3,378
-11% -$207K 0.06% 154
2023
Q2
$1.88M Buy
29,425
+670
+2% +$44.9K 0.07% 165
2023
Q1
$1.99M Sell
28,755
-50
-0.2% -$3.53K 0.07% 167
2022
Q4
$2.07M Sell
28,805
-2,174
-7% -$164K 0.08% 145
2022
Q3
$2.2M Buy
30,979
+309
+1% +$22.4K 0.1% 136
2022
Q2
$2.36M Buy
30,670
+3,147
+11% +$240K 0.1% 133
2022
Q1
$2.01M Sell
27,523
-925
-3% -$62.1K 0.07% 151
2021
Q4
$1.75M Sell
28,448
-2,778
-9% -$163K 0.06% 164
2021
Q3
$1.85M Sell
31,226
-1,347
-4% -$88.7K 0.07% 160
2021
Q2
$2.18M Buy
32,573
+1,084
+3% +$70.7K 0.09% 130
2021
Q1
$1.99M Buy
31,489
+532
+2% +$33.1K 0.1% 122
2020
Q4
$1.92M Sell
30,957
-1,261
-4% -$77.5K 0.11% 122
2020
Q3
$1.93M Buy
32,218
+1,090
+4% +$65.6K 0.12% 114
2020
Q2
$1.83M Sell
31,128
-1,907
-6% -$114K 0.13% 116
2020
Q1
$1.84M Sell
33,035
-1,437
-4% -$87.8K 0.15% 108
2019
Q4
$2.21M Buy
34,472
+5,131
+17% +$294K 0.15% 110
2019
Q3
$1.49M Sell
29,341
-494
-2% -$23.2K 0.11% 116
2019
Q2
$1.35M Sell
29,835
-2,106
-7% -$98.1K 0.1% 116
2019
Q1
$1.52M Sell
31,941
-3,205
-9% -$160K 0.11% 118
2018
Q4
$1.83M Sell
35,146
-2,335
-6% -$125K 0.17% 101
2018
Q3
$2.33M Sell
37,481
-1,098
-3% -$65.2K 0.18% 96
2018
Q2
$2.13M Sell
38,579
-153,579
-80% -$8.29M 0.18% 98
2018
Q1
$12.2M Sell
192,158
-9,352
-5% -$602K 1.02% 31
2017
Q4
$12.3M Buy
201,510
+46,172
+30% +$2.89M 1% 34
2017
Q3
$9.9M Sell
155,338
-4,602
-3% -$269K 0.84% 43
2017
Q2
$8.91M Sell
159,940
-1,063
-0.7% -$57.8K 0.79% 45
2017
Q1
$8.76M Buy
161,003
+48,918
+44% +$2.68M 0.78% 46
2016
Q4
$6.55M Buy
112,085
+68,195
+155% +$3.73M 0.63% 67
2016
Q3
$2.37M Sell
43,890
-1,849
-4% -$119K 0.22% 92
2016
Q2
$3.36M Sell
45,739
-2,017
-4% -$143K 0.32% 83
2016
Q1
$3.05M Sell
47,756
-860
-2% -$54.2K 0.29% 84
2015
Q4
$3.46M Buy
+48,616
New +$3.21M 0.33% 80

Other funds holding BMY

Citizens Financial Group's BMY Position: Q1 2026 in Review

Citizens Financial Group increased its Bristol-Myers Squibb (BMY) stake by 54% in Q1 2026, buying an estimated $1.64M and bringing the position to 80,552 shares worth $4.89M. The position accounts for 0.07% of the portfolio, ranked #185.

Citizens Financial Group first reported a position in BMY in Q4 2015 and has held it in 42 quarters since. The position peaked at $12.3M in Q4 2017. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Citizens Financial Group held 80,552 shares of Bristol-Myers Squibb worth $4.89M as of Q1 2026.
  • Citizens Financial Group bought 28,098 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.64M.
  • Bristol-Myers Squibb made up 0.07% of Citizens Financial Group's portfolio in Q1 2026, its #185 holding.
  • Citizens Financial Group first reported a position in Bristol-Myers Squibb in Q4 2015 and has held it in 42 quarters since.
  • Citizens Financial Group's Bristol-Myers Squibb position peaked at $12.3M in Q4 2017.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Citizens Financial Group's 13F filing for Q1 2026, filed 1 May 2026.